InvestorIdeas.com Newswire

Tuesday, November 24, 2015

Zacks Small Cap Research Maintains Buy Rating on Aethlon Medical (AEMD); Valued at $18 Share

Zacks Small Cap Research Maintains Buy Rating on Aethlon Medical (AEMD); Valued at $18 Share

Point Roberts WA, NEW YORK, NY – November 23, 2015 - Investorideas.com, a global digital news source covering leading sectors including biotech and medical technology reports new equity research on Aethlon Medical, Inc. (AEMD) was released by ZACKS SMALL CAP RESEARCH last week.  Analyst Brian Marckx, CFA maintains a buy rating with the following notes: 

“Current market discount rate, calculated by CAPM is approximately 9%.  Based on our DCF model and a 9% discount rate, AEMD is valued at approximately $18/share.  We are maintaining our Buy rating.  See below for access to our updated report on AEMD.  “


Operational Update:  Meets All 5 Objectives, Aethlon ADAPT, Additional Progress…

On the fiscal first quarter conference call in August management laid out five specific objectives that they planned to accomplish over the following months.  They successfully did so and went through each one on the Q2 call, which we have provided an update to below.  But in addition to meeting these goals the company also made parallel progress in not only further shoring up their operational capabilities in preparation for increased activities related to both the HCV and cancer applications but also made strides in broadening the scope of potential applications where their technology might be applied. 

A recap and update to the five objectives that the company laid out on the Q1 call in August….

- Collect an additional ~$200k under the DAPRA contract which relates to year 4.  Hope to be granted year 5 of the contract (which was subsequently awarded).  Accomplished with $186k collected in Q2 and DARPA year 5 awarded in September. 

- Submission of manuscript of the DETECT (Diagnosing and Evaluating Traumatic Encephalopathy Using Clinical Tests) study.  As a reminder, since late last calendar year Aethlon’s majority-owned subsidiary Exosome Sciences (ESI) has collaborated with Boston University’s CTE Center for the development of a blood-based diagnostic that would be able to identify CTE in living individuals.  ESI has used what they learned in how to isolate certain brain-specific biomarkers to evaluate blood samples collected by participants (former NFL players and a control group) enrolled in BU's DETECT study.  The study is the first on CTE funded by the NIH. Aethlon submitted the manuscript subsequent to the Q1 call.  Management noted on the Q2 call that they think it could be published within the next ~60 days.  As an aside, the night before AEMD’s earnings call there was a timely 60 Minutes story about BU’s CTE study and the blood-based diagnostic that AEMD’s Exosome Sciences is helping lead the development of. 

- Accelerate cancer study with University of California, Irvine.  As a reminder, in mid-April AMED announced that they entered an agreement with UC, Irvine to conduct an investigator-initiated study with various cancer types including breast, colorectal lung, head and neck and others.  Targeted enrollment is five patients in each of nine cancer types (45 patients total) including breast adenocarcinoma, colorectal, gastric and gastroesophageal, pancreatic, cholangiocarcinoma, lung, head and neck, melanoma and ovarian adenocarcinoma.  The proposed study protocol, Plasma Exosome Concentration in Cancer Patients Undergoing Treatment”, will monitor changes in circulating exosome levels and their association with cancer treatment and response to treatment.  In May AEMD announced that UC, Irvine Medical Center approved an IRB to commence the study.  AEMD noted on the Q2 call that this study has commenced and has now enrolled three patients so far.        

- Advance additional collaborations for Hemopurifier in cancer and infectious diseases.  As a reminder, Hemopurifier has shown potential utility in HCV, HIV, Ebola, other pandemic diseases, bioterror applications, cancer and other areas.  AEMD is clearly focused on deepening and broadening the potential applications that their device may have utility for.  In June the company announced an agreement with the India’s National Institute of Virology to commence testing of Hemopurifier for treatment of Chikungunya.  Management also noted on the Q2 call that they have initiated a research project with the National Center for Biodefense and Infectious Diseases to investigate the use of Hemopurifier in Venezuelan equine encephalitis.  AEMD has had a relationship with the National Center for Biodefense and Infectious Diseases for over ten years and this latest announcement appears to be further progress towards working with the center for applications of AEMD’s technology in addressing biological threats.  

- Initiate the U.S. HCV feasibility study and transition Dr. Stephen Fadem from principal investigator of the study to a medical advisory role within the company.  Subsequent to the Q1 call that transition was made and Dr. Ronal Ralph was brought on as the new principal investigator.  AEMD expects to hire two sub-principal investigators to help further accelerate the trial schedule.  And while progression of the study has been drawn out longer than initially anticipated, AEMD noted on the Q2 call that they expect to have the new study team trained after Thanksgiving and begin new patient enrollment in January.  


Additional equity research coverage is published on Investorideas.com from third party firms http://www.investorideas.com/Research/

About Aethlon Medical, Inc. (AEMD)
Aethlon Medical creates affinity biofiltration devices to treat life-threatening diseases. Our lead therapeutic candidate is the Aethlon Hemopurifier®, a first-in-class device that targets the rapid elimination of infectious viruses and cancer-promoting exosomes from the circulatory system of treated individuals. U.S. clinical progression of Hemopurifier therapy is being advanced under an FDA approved clinical study. We also provide government contracting services to the Defense Advanced Research Projects Agency related to the development of a biofiltration device to treat sepsis. Additional information can be found online at www.AethlonMedical.com or you can connect with us on Twitter, LinkedIn, Facebook and Google+.


InvestorIdeas.com is a global investor news source that follows the money in leading sectors including biotech and medical technology.  www.investorideas.com

Disclaimer/Disclosure: The Investorideas.com newswire is a third party publisher of news and research as well as creates original content as a news source. Original content created by investorideas is protected by copyright laws other than syndication rights. Investorideas is a news source on Google news and Linkedintoday plus hundreds of syndication partners. Our site does not make recommendations for purchases or sale of stocks or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investment involves risk and possible loss of investment. This site is currently compensated by featured companies, news submissions, content marketing and online advertising. Contact each company directly for press release questions. Disclosure is posted on each release if required but otherwise the news was not compensated for and is published for the sole interest of our readers. Disclosure: Investoridease.com has been compensated by AEMD for news publication and social media http://www.investorideas.com/About/Disclaimer.asp  and http://www.investorideas.com/About/News/Clientspecifics.asp   

Contact Investorideas.com
800 665 0411


JOIN Investorideas.com for Cyber Monday

JOIN Investorideas.com for Cyber Monday

50% off our annual membership – one year for just $48.50

Get Trading Ideas all year long for just over 0.13 a day!!!

 

 

Find great stocks in your favorite stock sector ... We have built lists of publicly traded stocks in each sector - microcap, small cap, large cap! We get you started... you find the ideas right for you!
From water stocks to gold and mining stocks, renewable energy, nanotech, defense, technology, biotech and more – use our stock directories and access them online 24/7 with login as a member to find your next big idea!
Just $48.50 a year

Sign Up Here

What do our Investor Ideas members get?

Exclusive Login access to our Global Stock Directories that are updated each month - thousands of stocks to research by sector...
Stocks listed may include the following stock exchanges: TSX, OTC, NASDAQ, NYSE, ASX, LSE – AIM, LSE – IRELAND, XETRA, FRANKFURT, BERLIN, EURONEXT, CHINA , HONG KONG, TOKYO, PARIS, MILAN, SPAIN, INDIA, MALAYSIA, SINGAPORE, MEXICO, ITALY, ARGENTINA, BRAZIL, TAIWAN, OSLO EXCHANGE (NORWAY), GREECE – ATHENS EXCHANGE, SWITZERLAND
*Due to the nature of the Investor Ideas members content, we do not offer trial memberships, in order to protect the proprietary stock directories. Therefore the membership is not refundable unless an incorrect purchase is made and we are notified immediately following the transaction the same day . Members are reminded the directories are for personal use only and not to be reproduced on other websites. Membership logins are not to be shared with other non- member users! Any violation of this will be taken very seriously.
Stock Directories Disclaimer
Investorideas.com paid stock directories are not guaranteed to be 100 % accurate but we do our best to update the directories and make edits and changes on a regular basis. Our stock directories do not include all publicly traded stocks within the sector but reflect a thorough representation of each sector we follow. All company descriptions are sourced from the company's public information.

About Investorideas.com - Big Ideas for Global Investors

InvestorIdeas.com - digital media global news source, PR and social media in leading sectors.
Sectors we cover include mining, energy, renewable energy, water stocks, food and beverage (including organic and LOHAS, wine), defense and security, biotech, technology and mobile. We have also recently expanded our global coverage to include Latin American stocks, the Middle East, sports and entertainment.
Disclaimer/Disclosure: The Investorideas.com newswire is a third party publisher of news and research as well as creates original content as a news source. Original content created by investorideas is protected by copyright laws other than syndication rights. Investorideas is a news source on Google news and Linkedintoday plus hundreds of syndication partners. Our site does not make recommendations for purchases or sale of stocks or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investment involves risk and possible loss of investment. This site is currently compensated by featured companies, news submissions, content marketing and online advertising. Contact each company directly for press release questions. Disclosure is posted on each release if required but otherwise the news was not compensated for and is published for the sole interest of our readers. Disclosure: http://www.investorideas.com/About/Disclaimer.asp 
BC Residents and Investor Disclaimer : Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894

Contact Investorideas.com

800 665 0411

Friday, September 11, 2015

Investorideas.com Announces its First Global ‘Follow the Money’ Contest


Investorideas.com Announces its First Global ‘Follow the Money’ Contest

New York NY- Point Roberts WA–September 11, 2015 -- Investorideas.com (www.investorideas.com), a global investor news source covering leading sectors
announces its first ever ‘Follow the Money’ contest for global investors.

The contest will run from September 15th to October 31st, 2015 and is open to Investor Ideas members. (http://www.investorideas.com/membership/)

Prizes include a ‘Money Suit’ as seen worn by the Investorideas.com Money Team and also by Will Ferrell at the 2013 MTV Movie Awards.  Prizes also include Annual Small Cap Pro Accounts from Investor Hub http://investorshub.advfn.com/ with more prizes to be announced shortly.

The contest will consist of investors picking a stock or stocks they wish to buy within sectors they like and within the time frame of the contest (either real trades or fictional trades). Investors can buy their favorite beverage stock such as Starbucks Corporation (SBUX) from our beverage stock directory, their favorite Yoga Brand like Lululemon Athletica Inc. (LULU) from our LOHAS directory or Ralph Lauren Corporation (RL) from our Luxury Brand stock directory.

This contest gives investors a chance to not only invest in their favorite sectors and companies but also to test their skills against other global investors.  Investorideas.com stock directories feature and include stocks from most global stock exchanges. Key sectors covered include biotech, tech, mining, mobile, energy, water, defense and security, renewable energy, food and beverage stocks including wine stocks, luxury retail brands, sports stocks and others.







More Info about Small Cap Pro: Small Cap Pro provides online Level 2 quotes for active stock traders. Users receive live Level 2 data for both OTCBB stocks and Pink Sheets. You will be able to use the Level 2 order book to see the buying support and selling pressure. This info will help determine when is a good time to buy or sell the stock. The Level 2 tool is available on the website or in the mobile apps.

This package also provides Level 1 stock quotes for all the web site tools such as monitor watchlists, charts, portfolio, last 100 trades, and toplists. This wide range of access provides live stock quotes everywhere you go. The data is unlimited so you are finally free to explore the world of stocks to your heart's content. Let our tools help you analyze and find the next great stock. Don't miss another great trading opportunity

About InvestorIdeas.com:
InvestorIdeas.com is a global news source for investors following leading business sectors including biotech, tech, mining, mobile, energy, water, defense and security, renewable energy, food and beverage stocks, sports and entertainment and Latin American stocks.
Follow Investorideas.com on Twitter http://twitter.com/#!/Investorideas
Follow Investorideas.com on Facebook http://www.facebook.com/Investorideas

Sign up for our free news alerts

Disclaimer/ Disclosure: The Investorideas.com newswire is a third party publisher of news and research as well as creates original content as a news source. Original content created by investorideas is protected by copyright laws other than syndication rights. Investorideas is a news source on Google news and syndication partners. Our site does not make recommendations for purchases or sale of stocks or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investment involves risk and possible loss of investment. This site is currently compensated by featured companies, news submissions, content marketing and online advertising. Contact each company directly for press release questions. Disclosure is posted on each release if required but otherwise the news was not compensated for and is published for the sole interest of our readers. More disclaimer info: http://www.investorideas.com/About/Disclaimer.asp

BC Residents and Investor Disclaimer : Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894. Global investors must adhere to regulations of each country.

To Sponsor the contest with your brand or service call or email

Dawn or Cali

800-665-0411 - Source – www.Investorideas.com





Tuesday, April 21, 2015

Drone Stocks Opportunity; Market for commercial/civilian drones to grow at a compound annual growth rate (CAGR) of 19% between 2015 and 2020



Drone Stocks Opportunity; Market for commercial/civilian drones to grow at a compound annual growth rate (CAGR) of 19% between 2015 and 2020

Point Roberts WA, NEW YORK, NY – April 21, 2015 - Investorideas.com, a global news source covering leading sectors including tech stocks updates its directory of drone stocks for investors as research shows the opportunity and market is growing rapidly.

In a recent report from BI Intelligence, reviewing the levels of the growing global industry for commercial drones, or unmanned aerial vehicles (UAVs), they noted the following:

“The global commercial drone market will take shape around applications in a handful of industries: agriculture, energy, utilities, mining, construction, real estate, news media, and film production.

Most growth in the drone industry is on the commercial/civilian side, as the shift away from the military market gains momentum. The market for commercial/civilian drones will grow at a compound annual growth rate (CAGR) of 19% between 2015 and 2020, compared with 5% growth on the military side.

E-commerce and package delivery will not be an early focus of the drone industry.

Legacy drone manufacturers focused mostly on military clients do not have a natural advantage in the fast-evolving civilian drone market.

Proposed US regulation would effectively end the ban on commercial drone flights and would allow low-altitude flights of small drones within view of a ground-based pilot.

The rules are unlikely to be finalized before early 2017. Some believe it will happen earlier. But we believe it most likely that widespread but heavily restricted commercial UAV flights will become routine sometime that year.

Technology barriers are at once a roadblock and a huge business opportunity.

Many of the notable early commercial UAV manufacturers are emerging outside of the US market: These include Switzerland-based senseFly (owned by France-based Parrot), Canadian firm Aeryon, publicly traded Swedish firm CybAero, Shenzhen, China-based DJI, and Korea-based Gryphon.

The commercial-drone industry is still young but has begun to see some consolidation and major investments from large industrial conglomerates, chip companies, and defense contractors.”



DRONE Stocks
AeroVironment, Inc. (NasdaqGS:AVAV) is a technology solutions provider that designs, develops, produces and supports an advanced portfolio of Unmanned Aircraft Systems (UAS) and electric transportation solutions.  Agencies of the U.S. Department of Defense and allied military services use the company’s electric-powered, hand-launched unmanned aircraft systems extensively to provide situational awareness to tactical operating units through real-time, airborne reconnaissance, surveillance and communication. AeroVironment’s electric transportation solutions include a comprehensive suite of electric vehicle (EV) charging systems, installation and network services for consumers, automakers, utilities and government agencies, power cycling and test systems for EV developers and industrial electric vehicle charging systems for commercial fleets.
Ambarella, Inc.  (NasdaqGS:AMBA) is a leading developer of low-power, high-definition and Ultra HD video compression and image processing solutions. The company's products are used in a variety of cameras including security IP-cameras, sports cameras, wearable cameras and automotive video camera recorders. Ambarella compression chips are also used in broadcasting TV programs worldwide. DRONES: Ambarella is at the forefront of a new generation of high-performance HD and Ultra-HD sports and flying cameras designed for the outdoor enthusiast.  These action cameras are expected to have small form factors and long battery lives, without sacrificing the advanced features that make vivid, clean video and professional-quality still images a reality.  Whether mounted on a quadcopter or worn while skiing, these devices are required to perform complex image stabilization functions, adapt to ever-changing lighting environments and communicate wirelessly with smartphones on-the-fly.  Ambarella addresses the demanding requirements of the sports and flying camera market by offering products that combine exquisite video and image quality, low power consumption, and best-in-class compression efficiency.
Boeing Co (NYSE: BA) is the world's largest aerospace company and the leading manufacturer of commercial jetliners and military aircraft combined. Additionally, Boeing designs and manufactures rotorcraft, electronic and defense systems, missiles, satellites, launch vehicles and advanced information and communication systems. As a major service provider to NASA, Boeing is the prime contractor for the International Space Station. The company also provides numerous military and commercial airline support services. Boeing provides products and support services to customers in 150 countries and is one of the largest U.S. exporters in terms of sales. Boeing has a long tradition of aerospace leadership and innovation. We continue to expand our product line and services to meet emerging customer needs. Our broad range of capabilities includes creating new, more efficient members of our commercial airplane family; integrating military platforms, defense systems and the warfighter through network-centric operations; creating advanced technology solutions that reach across business units; e-enabling airplanes and providing connectivity on moving platforms; and arranging financing solutions for our customers. DRONES: Boeing and The Insitu Group have developed and built a low-cost, long-endurance autonomous unmanned vehicle, called ScanEagle. ScanEagle is based on Insitu's Seascan miniature robotic aircraft and draws on Boeing's systems integration, communications and payload technologies. The Unmanned Little Bird Demonstrator is a modified MD 530F single-turbine helicopter designed for optionally manned flight. It won the AHS 2005 Grover E. Bell award for the best advancement in rotorcraft research that year. The platform is capable of dual pilot, single pilot or no pilot flight operations. It can be remotely operated or programmed for autonomous operations in any of these operational modes.
Drone Aviation Holding Corp. (OTC: DRNE) provides critical aerial and land based surveillance and communications solutions to government and commercial customers. Utilizing a unique tethering capability, drone systems operate in the National Airspace within FAA guidelines for safe operations. Drone systems are designed and developed in-house utilizing proprietary technologies and processes that result in compact, rapidly deployable aerostat solutions and mast based systems to fulfill critical requirements by the military and law enforcement in the U.S. and to our allies around the world.
Facebook (NasdaqGS:FB) operates as a social networking company worldwide. The company builds tools that enable users to connect, share, discover, and communicate with each other; enables developers to build social applications on Facebook or to integrate their Websites with Facebook; and offers products that enable advertisers and marketers to engage with its users. DRONES: Ascenta - Announcing the Connectivity Lab at Facebook, a team that is working on new aerospace and communication technologies to advance the Internet.org mission of improving and extending internet access. The Lab, which includes some of the world’s top experts from Ascenta, NASA’s Jet Propulsion Laboratory, NASA’s Ames Research Center, and the National Optical Astronomy Observatory, is already working on new delivery platforms including planes and satellites to provide connectivity. The Connectivity Lab at Facebook is developing ways to make affordable internet access possible in communities around the world. The team is exploring a variety of technologies, including high-altitude long-endurance planes, satellites and lasers.
Google Inc. (NasdaqGS:GOOGL) is a global technology company. The Company’s business is primarily focused around key areas, such as search, advertising, operating systems and platforms, enterprise and hardware products. In April 2014, Google Inc acquired Titan Aerospace, a Moriarty-based manufacturer of solar-powered drones. Google / Titan Aerospace is a manufacturer of solar-powered Unmanned Aerial Vehicles (UAV). The Company operates a research and development facility located in Moriarty, New Mexico, where it is working with the FAA to obtain airspace for flight testing within the National Airspace System and Special Airworthiness Certification for its Solara aircraft.
InvenSense, Inc. (NYSE:INVN) is the world`s leading provider of intelligent sensor system on chip (SoC) for Motion and Sound in consumer electronic devices. The company`s patented InvenSense Fabrication Platform and MotionFusion® technology address the emerging needs of many mass-market consumer applications via improved performance, accuracy, and intuitive motion-, gesture- and sound-based interfaces. InvenSense technology can be found in Mobile, Wearables, Smart Home, Industrial, and Automotive products. InvenSense is headquartered in San Jose, California and has offices in Boston, China, Taiwan, Korea, Japan, France, Canada, Slovakia and Italy. DRONES: The MPU-3300 offers industry best performance in harsh industrial environments where extreme temperature ranges, and severe shocks are present. Applications that can be addressed with the MPU-3300 include Attitude Heading Reference Systems (AHRS) for Aerospace and Robotics; Navigation Systems for Industrial Vehicles, Aircraft, and Ships; Platform and Antenna Stabilization, Precision Robotics, Inventory Control Systems, Survey Instruments, Factory Equipment, Industrial Power Tools, Unmanned Aerial Vehicles, Precision Agriculture Machinery, Guidance and Steering Applications, and Construction Equipment.
Lockheed Martin Corp. (NYSE: LMT) Headquartered in Bethesda, Md., Lockheed Martin is a global security company that employs about 113,000 people worldwide and is principally engaged in the research, design, development, manufacture, integration and sustainment of advanced technology systems, products and services. DRONES: The K-MAX unmanned cargo helicopter keeps forward operating bases supplied, reducing the number of truck convoys – and the troops that protect them – on the dangers roads of Afghanistan. Unmanned aerial systems like Desert Hawk III enables soldiers to see what’s over the next hill, while persistent surveillance platforms like PTDS, High Altitude Airship, Hybrid Air Vehicle and ISIS can keep eyes in the sky over vast areas for weeks, months and even years at a time.
Northrop Grumman Corporation (NYSE: NOC) is a leading global security company providing innovative systems, products and solutions in unmanned systems, cybersecurity, C4ISR, and logistics and modernization to government and commercial customers worldwide. Unmanned Air Systems/Drones
Textron Inc. (NYSE: TXT) is a multi-industry company that leverages its global network of aircraft, defense, industrial and finance businesses to provide customers with innovative solutions and services. Textron is known around the world for its powerful brands such as Bell Helicopter, Cessna Aircraft Company, Beechcraft, Hawker, Jacobsen, Kautex, Lycoming, E-Z-GO, Greenlee and Textron Systems. DRONES: Textron Systems’ businesses develop and integrate products, services and support for aerospace and defense customers, as well as civil and commercial customers including those in law enforcement, security, border patrol and critical infrastructure protection around the globe. Harnessing agility and a broad base of expertise, Textron Systems’ innovative businesses design, manufacture, field and support comprehensive solutions that expand customer capabilities and deliver value. Textron Systems consists of its Advanced Information Solutions, Electronic Systems, Geospatial Solutions, Lycoming Engines, Marine & Land Systems, Support Solutions, TRU Simulation + Training, Unmanned Systems and Weapon & Sensor Systems businesses.
Become an Investorideas.com Member and access our online stock directories listing thousands of publicly traded stocks in leading sectors including tech stocks: http://www.investorideas.com/membership/

Sectors we cover in include mining, energy, renewable energy, water stocks, food and beverage (including organic and LOHAS, wine), defense and security, biotech, technology and mobile. We have also recently expanded our global coverage to include Latin American stocks, sports and entertainment.

Follow Investorideas.com on Twitter http://twitter.com/#!/Investorideas
Follow Investorideas.com on Facebook http://www.facebook.com/Investorideas

Sign up for free news alerts at Investorideas.com

Disclaimer/ Disclosure: The Investorideas.com newswire is a third party publisher of news and research as well as creates original content as a news source. Original content created by investorideas is protected by copyright laws other than syndication rights. Investorideas is a news source on Google news syndication partners. Our site does not make recommendations for purchases or sale of stocks or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investment involves risk and possible loss of investment. This site is currently compensated by featured companies, news submissions, content marketing and online advertising. Contact each company directly for press release questions. Disclosure is posted on each release if required but otherwise the news was not compensated for and is published for the sole interest of our readers. More disclaimer info: http://www.investorideas.com/About/Disclaimer.asp
BC Residents and Investor Disclaimer : Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894. Global investors must adhere to regulations of each country.

Contact Investorideas.com
800 665 0411


Thursday, April 16, 2015

Big Day for IPO’s; Etsy, Inc. (ETSY) More than Doubles on Market Debut


Big Day for IPO’s; Etsy, Inc. (ETSY) More than Doubles on Market Debut

Point Roberts WA, NEW YORK, NY – April 16, 2015 - Investorideas.com, a global news source for investors covering leading sectors reports on the IPO of Etsy, Inc. (ETSY), a marketplace where people around the world connect, both online and offline, to make, sell and buy unique goods. Its initial public offering of 16,666,666 shares of its common stock at a price to the public of $16.00 per share is looking good to shareholders as the stock hit a high of $35.74 in the opening session.

The stock is currently trading at $30.05.





About Etsy
Etsy is a marketplace where millions of people around the world connect, both online and offline, to make, sell and buy unique goods. The Etsy ecosystem includes entrepreneurs who sell on our platform, consumers looking to buy unique goods in our marketplace, manufacturers who help Etsy sellers grow their businesses and Etsy employees who maintain our platform. Etsy was founded in 2005 and is headquartered in Brooklyn, New York.

InvestorIdeas.com newswire is a global recognized news source. We publish original content, third party investment commentary, contributor articles, company news and press releases in leading sectors.
Sectors we cover in include mining, energy, renewable energy, water stocks, food and beverage (including organic and LOHAS, wine), defense and security, biotech, technology and mobile. We have also recently expanded our global coverage to include Latin American stocks, sports and entertainment.

Follow Investorideas.com on Twitter http://twitter.com/#!/Investorideas
Follow Investorideas.com on Facebook http://www.facebook.com/Investorideas

Sign up for free news alerts at Investorideas.com

Become an Investorideas.com Member and access our online stock directories listing thousands of publicly traded stocks in leading sectors  

Disclaimer/ Disclosure: The Investorideas.com newswire is a third party publisher of news and research as well as creates original content as a news source. Original content created by investorideas is protected by copyright laws other than syndication rights. Investorideas is a news source on Google news syndication partners. Our site does not make recommendations for purchases or sale of stocks or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investment involves risk and possible loss of investment. This site is currently compensated by featured companies, news submissions, content marketing and online advertising. Contact each company directly for press release questions. Disclosure is posted on each release if required but otherwise the news was not compensated for and is published for the sole interest of our readers. More disclaimer info: http://www.investorideas.com/About/Disclaimer.asp
BC Residents and Investor Disclaimer : Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894. Global investors must adhere to regulations of each country.

Contact Investorideas.com
800 665 0411


Wednesday, April 08, 2015

Aethlon Medical (OTCBB: AEMD) Announces Reverse Stock Split and Nasdaq Listing Submission

Medical Technology Breaking News: Aethlon Medical (OTCBB: AEMD) Announces Reverse Stock Split and Nasdaq Listing Submission

SAN DIEGO - April 8, 2015 (Investorideas.com newswire) Aethlon Medical, Inc. (OTCBB:AEMD), a pioneer in developing targeted therapeutic devices to address infectious diseases and cancer, announced today that it will implement a 1-for-50 reverse split of its common stock. The implementation of the reverse stock split is subject to approval by the Financial Industry Regulatory Authority (FINRA). Upon approval by FINRA, the Company's common stock will trade on a split-adjusted basis under the temporary symbol "AEMDD," with the "D" appended to signify that the reverse stock split has occurred. The trading symbol will revert to "AEMD" after approximately 20 trading days. We currently anticipate that FINRA will approve the reverse stock split on April 10, 2015, however there can be no assurance that the effectiveness of the reverse stock split will occur on that date.


The Company also announced that it has submitted an initial listing application with the Nasdaq Stock Market to have its common stock approved for listing on the Nasdaq Capital Market. The Company's Board of Directors approved the stock split in part to support the Nasdaq Capital Market listing application. At present, the Company does not meet all of the initial listing requirements of the Nasdaq Capital Market and therefore the Company cannot assure that the listing will be approved.

The reverse split will reduce the number of shares of the Company's common stock outstanding from approximately 323 million to approximately 6.7 million. Proportional adjustments will be made to the Company's authorized shares, and to the terms and exercise price of outstanding options and warrants, as well as the conversion terms of the Company's outstanding convertible notes. Any fractional shares resulting from the reverse stock split will be rounded up to the next whole share.

INFORMATION FOR STOCKHOLDERS
Upon the effectiveness of the reverse stock split, each fifty shares of issued and outstanding common stock will be converted into one share of the Company's common stock. Stockholders who have existing stock certificates will receive written instructions by mail from the Company's transfer agent, Computershare. Stockholders who hold their shares in brokerage accounts or "street name" are not required to take any action to effect the exchange of their shares. Such stockholders will be contacted by their brokers with instructions.


About Aethlon Medical, Inc.
Aethlon Medical creates medical devices that target unmet therapeutic needs in infectious disease and cancer. The company's lead product is the Aethlon Hemopurifier®, a first-in-class device that selectively targets the rapid elimination of circulating viruses and tumor-secreted exosomes that promote cancer progression. Exosome Sciences, Inc. is a majority owned subsidiary that is advancing exosome-based products to diagnose and monitor cancer, infectious disease and neurological disorders. Additional information can be found on-line at http://www.aethlonmedical.com/ and connect with the Company on Twitter, LinkedIn, Facebook and Google+.

Certain statements herein may be forward-looking and involve risks and uncertainties. Such forward-looking statements involve assumptions, known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of Aethlon Medical, Inc. to be materially different from any future results, performance, or achievements expressed or implied by the forward-looking statements. Such potential risks and uncertainties include, without limitation, that Exosome Sciences, Inc. will not be able to commercialize its future products, including any that can be described as a liquid biopsy, that the FDA will not approve the initiation of the Company's clinical programs or provide market clearance of the company's products, future human studies whether revenue or non-revenue generating of the Aethlon ADAPT™ system or the Aethlon Hemopurifier® as an adjunct therapy to improve patient responsiveness to established cancer or hepatitis C therapies or as a standalone cancer or hepatitis C therapy or as a broad spectrum defense against viral pathogens, including Ebola, the Company's ability to raise capital when needed, the Company's ability to complete the development of its planned products, the Company's ability to manufacture its products either internally or through outside companies and provide its services, the impact of government regulations, patent protection on the Company's proprietary technology, the ability of the Company to meet the milestones contemplated in the DARPA contract, product liability exposure, uncertainty of market acceptance, competition, technological change, and other risk factors. In such instances, actual results could differ materially as a result of a variety of factors, including the risks associated with the effect of changing economic conditions and other risk factors detailed in the Company's Securities and Exchange Commission filings. The Company undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise.

Contacts:
James A. Joyce 
Chairman and CEO
 
858.459.7800 x301
 
jj@aethlonmedical.com

Jim Frakes 
Chief Financial Officer
 
858.459.7800 x300
 
jfrakes@aethlonmedical.com

David Zazoff 
MDM Worldwide Solutions
 
646-403-3554

Visit this company: www.aethlonmedical.com

More info on AEMD at Investorideas.com Visit: http://www.investorideas.com/CO/AEMD/

Sign up for the free investor news and stock alerts:

Disclaimer/Disclosure: The Investorideas.com newswire is a third party publisher of news and research as well as creates original content as a news source. Original content created by investorideas is protected by copyright laws other than syndication rights. Investorideas is a news source on Google news and Linkedintoday plus hundreds of syndication partners. Our site does not make recommendations for purchases or sale of stocks or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investment involves risk and possible loss of investment. This site is currently compensated by featured companies, news submissions, content marketing and online advertising. Contact each company directly for press release questions. Disclosure is posted on each release if required but otherwise the news was not compensated for and is published for the sole interest of our readers. More disclaimer info: http://www.investorideas.com/About/Disclaimer.asp Disclosure: AEMD subscribes to the Investorideas newswire content publishing annual program (9700 per Year, paid quarterly) for news publishing.
BC Residents and Investor Disclaimer: Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894. Global investors must adhere to regulations of each country.

Become an Investorideas.com Member and access our 14 online stock directories 24/7 –biotech, defense, mining stocks, oil and gas stocks and more...

Friday, March 27, 2015

Investor Ideas Joins Green Rush Alliance Following Launch of Marijuana Stocks Content




Investor Ideas Joins Green Rush Alliance Following Launch of Marijuana Stocks Content

Point Roberts WA, NEW YORK, NY – March 27, 2015 - Investorideas.com, a global investor news source covering leading sectors including agriculture stocks and marijuana/hemp stocks, reports it has joined The Green Rush Alliance  (http://www.greenrushalliance.com/) to build on its content and expand its presence in the sector.

Investorideas.com recently launched new featured content for investors following the sector, including news, analyst commentary and a growing directory of publicly traded companies.

The Green Rush Alliance (http://www.greenrushalliance.com/) was formed to bring together industry changing companies and technologies, as well as like-minded individuals to advance the marijuana industry through experience, knowledge, education, and an in-depth understanding of the components required to achieve success in this business. 

“It's All About The Medicine!- We are Advocates for the Industry as a whole, but believe that the strength of what we are doing lies within the medicine, research, patient wellness, patient education and promoting energy efficient products and technologies.”- The Green Rush Alliance

Marijuana /hemp stocks content at Investorideas.com: http://www.investorideas.com/Marijuana-Stocks/


Marijuana/Hemp Stocks Directory (Preview)
ABATTIS BIOCEUTICALS (OTC:ATTBF) is a specialty biotechnology company with capabilities through its wholly owned subsidiaries of cultivating, licensing and marketing proprietary ingredients, bio-similar compounds, patented equipment and consulting services to medicinal markets in North America. The Company is positioned to capitalize on the fast growing trend toward marijuana legalization in the United States and for medicinal use in Canada and international jurisdictions, by supplying and partnering with companies to employ its mass cultivation systems, extraction equipment/technology, and strategic marketing support to licensed growers. The Company also has an extensive pipeline of high-quality products and intellectual property for the rapidly expanding botanical drug market. We follow strict standard operating protocols, and adhere to the applicable laws of Canada and foreign jurisdictions.
Advanced Cannabis Solutions, Inc. (OTC:CANN) provides services to the regulated cannabis industry throughout the United States. We will lease growing space and related facilities (commercial real estate and equipment) to licensed marijuana business operators for their production needs. We are pursuing ancillary business products and services including customized finance, capital formation, banking, regulatory compliance consulting and advanced logistical support for grow operations. ACS does not grow, harvest, distribute or sell cannabis or any substances that violate United States law or the Controlled Substances Act, nor does it intend to do so in the future.
AFFINOR GROWERS (CNSX:AFI; OTC:RSSFF) is focused on growing high quality crops such as romaine lettuce, spinach, strawberries and high quality medical Marijuana. Affinor is committed to becoming a pre-eminent grower, using exclusive vertical farming techniques.
Agritek Holdings Inc (OTC:AGTK) a fully reporting Company and pioneer within the medicinal marijuana space provides innovative patient and agricultural solutions seeks to be the leader in Compassionate Care Technology for the medicinal marijuana industry. Agritek Holdings provides real estate management and health and wellness product lines through its wholly-owned subsidiary, Agritek Holdings Inc.  Agritek Holdings Inc. does not directly grow, harvest, or distribute or sell cannabis or any substances that violate United States law or the Controlled Substances Act, nor does it intend to do so in the future.
American Green Inc (OTC:ERBB) Founded back in 2009 as one of the first publicly-traded medical marijuana-related companies in the world, American Green is proud to have the largest certified shareholder base which now numbers well over 50,000. The Company is keenly focused on developing, retailing, branding, and establishing commercial cultivation solutions under its proprietary American Green name along with our partners who are licensed retail medical marijuana dispensaries. American Green believes that the renewal of the legalized cannabis industry in the United States will aid in getting our economy back on its feet through increased employment in all related sectors -- retail, real estate, contracting, farming and more. Additional revenues, fueled by taxing cannabis sales, and the decreased cost of housing prisoners who are no longer in prison for possession of cannabis should contribute to the renewal. Hard work and a clear vision propel American Green into the future. The centerpiece of our company is ZaZZZ, our unique automated vending solution designed specifically around American Green's licensed proprietary patent technology.
Aphria Inc (TSX: APH.V) a company continued under the laws of the Province of Ontario and based in Leamington, Ontario, is in the business of producing, supplying and selling medical marijuana pursuant to the Marihuana for Medical Purposes Regulations (the "MMPR"). Under the MMPR, Health Canada is responsible for the oversight of commercial medical marijuana growers such as Aphria.
Bedrocan Cannabis Corp (TSX:BED.V) is the global leader in medicinal cannabis research and product innovation and has been producing and supplying government-regulated medicinal cannabis for 13 years. Bedrocan’s strains of pharmaceutical-grade cannabis are used by patients in seven countries, including Canada. The company is committed to clinical research, with ISO 9001-rated production processes and product development, on an international scale. Bedrocan is one of only two companies currently supplying pharmaceutical-grade medicinal cannabis in Canada.
See full directory and other stock directories at Investor Ideas Members Page:

InvestorIdeas.com newswire is a global recognized news source. We publish original content, third party investment commentary, contributor articles, company news and press releases in leading sectors.
Sectors we cover in include mining, energy, renewable energy, water stocks, food and beverage (including organic and LOHAS, wine), defense and security, biotech, technology and mobile. We have also recently expanded our global coverage to include Latin American stocks, sports and entertainment.

Follow Investorideas.com on Twitter http://twitter.com/#!/Investorideas
Follow Investorideas.com on Facebook http://www.facebook.com/Investorideas

Sign up for free news alerts at Investorideas.com

Become an Investorideas.com Member and access our online stock directories listing thousands of publicly traded stocks in leading sectors  

Disclaimer/ Disclosure: The Investorideas.com newswire is a third party publisher of news and research as well as creates original content as a news source. Original content created by investorideas is protected by copyright laws other than syndication rights. Investorideas is a news source on Google news syndication partners. Our site does not make recommendations for purchases or sale of stocks or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investment involves risk and possible loss of investment. This site is currently compensated by featured companies, news submissions, content marketing and online advertising. Contact each company directly for press release questions. Disclosure is posted on each release if required but otherwise the news was not compensated for and is published for the sole interest of our readers. More disclaimer info: http://www.investorideas.com/About/Disclaimer.asp . Investorideas was not compensated by any of the companies in this article.
BC Residents and Investor Disclaimer : Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894. Global investors must adhere to regulations of each country.

Contact Investorideas.com
800 665 0411